AstraZeneca, a British pharmaceutical company, plans to invest $50 billion in the United States. This decision comes amid upcoming tariff increases from Washington. A significant portion of the investment will be used to construct a large manufacturing facili…
AstraZeneca to invest $50 bn in the US amid Trump tariffs
